Mounjaro can be prescribed for glycemic control of adult patients with type II diabetes.
Please note that this medication is custom compounded for each patient and it can take 5-7 days for the medication to be prepared and shipped. Each vial comes with 2mL of medication and 4 needles, which is enough for 4 weeks.
Mounjaro (generic name: tirzepatide) is an injectable prescription medicine that is used to treat adults with type 2 diabetes mellitus. It is prescribed along with diet and exercise to improve control of blood sugar levels. Mounjaro can be used as a single therapy or with other diabetes medicines.
Tirzepatide acts in much the same way as Ozempic (a weekly injection) and Rybelsus (a daily oral medication). Ozempic supplies a glucagon-like peptide-1 (GLP-1), which is also one of the main components of Mounjaro. Mounjaro also supplies glucose-dependent insulinotropic polypeptide (GIP) agonists. GLP-1 blocks the production of glucagon. These three drugs also produce substantial benefits in sustainable weight reduction.
Mounjaro is not for use in people with type 1 diabetes.
Mounjaro should be injected subcutaneously once each week on the same weekday at any time of the day. Do not use the same site for each injection but administer in rotation in the abdomen, thigh, or upper arm.
If taking insulin and Mounjaro simultaneously, do not mix them together in the same injection. One may administer injections of Mounjaro and insulin in the same body area, but not right next to each other.
Carefully read the information and follow instructions on the manufacturer’s Product Insert leaflet that comes with the medication to ensure safe usage. Failure to do so may result in serious health complications, and we will not be held liable for any harm caused by incorrect usage.